HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sebastiano Gangemi Selected Research

Skin Manifestations

6/2015Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity.
7/2014Urticaria and bacterial infections.
12/2013IL-33/IL-31 axis: a new pathological mechanisms for EGFR tyrosine kinase inhibitors-associated skin toxicity.
4/2011Urticaria and thyroid autoimmunity.
6/2004Montelukast-induced generalized urticaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sebastiano Gangemi Research Topics

Disease

49Neoplasms (Cancer)
04/2024 - 04/2003
38Inflammation (Inflammations)
05/2024 - 08/2003
25Hypersensitivity (Allergy)
05/2024 - 05/2003
21Asthma (Bronchial Asthma)
04/2023 - 06/2002
16Multiple Myeloma
02/2024 - 12/2011
16Atopic Dermatitis (Atopic Eczema)
10/2023 - 10/2015
13Psoriasis (Pustulosis Palmaris et Plantaris)
10/2023 - 09/2016
12Autoimmune Diseases (Autoimmune Disease)
12/2023 - 06/2011
12Infections
01/2023 - 01/2015
11Hematologic Neoplasms (Hematological Malignancy)
02/2024 - 10/2019
11COVID-19
01/2023 - 06/2020
10Urticaria (Hives)
06/2023 - 04/2003
8Osteoporosis
06/2022 - 03/2015
7Chronic Disease (Chronic Diseases)
10/2023 - 01/2016
6Anaphylaxis (Anaphylactic Shock)
05/2024 - 01/2009
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2024 - 01/2012
6Chronic Urticaria
10/2023 - 04/2017
6Chronic Obstructive Pulmonary Disease (COPD)
02/2023 - 01/2015
6Lung Diseases (Lung Disease)
02/2023 - 01/2009
6Leukemia
12/2022 - 01/2014
6Pruritus (Itching)
06/2021 - 07/2012
5Mental Disorders (Mental Disorder)
12/2023 - 03/2020
5Allergic Contact Dermatitis
04/2023 - 09/2009
5Allergic Rhinitis
02/2023 - 06/2004
5Systemic Scleroderma (Systemic Sclerosis)
01/2022 - 06/2017
5Skin Manifestations
06/2015 - 06/2004
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2024 - 06/2015
4Lymphoma (Lymphomas)
08/2023 - 10/2015
4Paraproteinemias (Monoclonal Gammopathy)
07/2023 - 10/2012
4Skin Diseases (Skin Disease)
12/2022 - 11/2017
4Neuroblastoma
10/2021 - 08/2015
4Rheumatoid Arthritis
07/2021 - 09/2016
4Vitiligo
07/2021 - 06/2015
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2021 - 01/2014
4Carcinogenesis
04/2021 - 01/2015
4Polycythemia Vera
10/2020 - 07/2012
4Carcinoma (Carcinomatosis)
03/2020 - 02/2005
4Rhinitis
08/2015 - 06/2002
3Multiple Sclerosis
10/2023 - 02/2021
3Skin Neoplasms (Skin Cancer)
07/2023 - 05/2020
3Melanoma (Melanoma, Malignant)
07/2023 - 01/2019
3Respiratory Tract Diseases (Respiratory Tract Disease)
01/2023 - 12/2021
3Cytokine Release Syndrome
11/2022 - 01/2021
3Bone Diseases (Bone Disease)
08/2022 - 01/2015
3Fibrosis (Cirrhosis)
03/2022 - 06/2017
3Schizophrenia (Dementia Praecox)
01/2022 - 03/2020
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2021 - 10/2015
3Contact Dermatitis (Eczema, Contact)
07/2021 - 01/2009
3Neurodegenerative Diseases (Neurodegenerative Disease)
03/2021 - 09/2016
3Autism Spectrum Disorder
03/2021 - 12/2018
3Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2015
3Parkinson Disease (Parkinson's Disease)
04/2020 - 08/2003
3Angioedema
01/2020 - 06/2004

Drug/Important Bio-Agent (IBA)

31CytokinesIBA
05/2024 - 10/2002
26Biomarkers (Surrogate Marker)IBA
01/2024 - 10/2012
25Proteins (Proteins, Gene)FDA Link
04/2024 - 08/2006
22Interleukin-33IBA
02/2024 - 03/2013
21MicroRNAs (MicroRNA)IBA
10/2023 - 01/2017
16AlarminsIBA
07/2023 - 01/2015
15InterleukinsIBA
01/2023 - 06/2003
12AntioxidantsIBA
04/2024 - 01/2015
12HMGB1 Protein (HMG1)IBA
07/2023 - 01/2015
10Advanced Oxidation Protein Products (AOPP)IBA
01/2022 - 01/2012
10Advanced Glycation End ProductsIBA
01/2022 - 01/2012
9Adrenal Cortex Hormones (Corticosteroids)IBA
05/2024 - 06/2002
9Vitamin DFDA LinkGeneric
08/2022 - 01/2014
8Reactive Oxygen Species (Oxygen Radicals)IBA
04/2024 - 08/2017
8Monoclonal AntibodiesIBA
07/2023 - 11/2017
7Interleukin-23 (Interleukin 23)IBA
06/2015 - 05/2011
6Immunoglobulin E (IgE)IBA
04/2023 - 01/2016
6Interleukin-22 (IL-22)IBA
07/2014 - 01/2009
5FlavonoidsIBA
05/2024 - 01/2014
5DNA (Deoxyribonucleic Acid)IBA
08/2023 - 01/2017
5AntibodiesIBA
08/2023 - 02/2006
5AllergensIBA
01/2023 - 04/2003
4EnzymesIBA
05/2023 - 06/2015
4VaccinesIBA
01/2023 - 01/2021
4Interleukin-17 (Interleukin 17)IBA
10/2022 - 05/2011
4Immunoglobulins (Immunoglobulin)IBA
06/2022 - 05/2011
4Interleukin-8 (Interleukin 8)IBA
02/2022 - 10/2002
4AntagomirsIBA
01/2021 - 08/2019
3Arthropod VenomsIBA
05/2024 - 01/2015
3Tyrosine Kinase InhibitorsIBA
04/2024 - 06/2015
3AntigensIBA
10/2023 - 01/2016
3PolyphenolsIBA
10/2023 - 01/2017
3Transcription Factors (Transcription Factor)IBA
08/2023 - 03/2022
3Malondialdehyde (Propanedial)IBA
08/2023 - 04/2003
3Hormones (Hormone)IBA
06/2023 - 01/2015
3Epinephrine (Adrenaline)FDA LinkGeneric
01/2023 - 01/2009
3Benzene (Benzole)IBA
11/2022 - 01/2014
3Interleukin-5 (Interleukin 5)IBA
11/2022 - 01/2016
3Interleukin-6 (Interleukin 6)IBA
06/2022 - 03/2021
3SteroidsIBA
11/2021 - 03/2015
3Therapeutic UsesIBA
10/2021 - 02/2005

Therapy/Procedure

44Therapeutics
05/2024 - 06/2004
7Drug Therapy (Chemotherapy)
11/2022 - 02/2005
5Immunotherapy
05/2024 - 10/2021
3Precision Medicine
06/2023 - 11/2022
3Biological Therapy
04/2023 - 12/2021
3Photochemotherapy (Photodynamic Therapy)
08/2021 - 05/2020